Rekha Hemrajani
Directeur/Membre du Conseil chez MAXCYTE, INC.
Fortune : 127 614 $ au 31/05/2024
Postes actifs de Rekha Hemrajani
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALX ONCOLOGY HOLDINGS INC. | Directeur/Membre du Conseil | 01/04/2020 | - |
Independent Dir/Board Member | 01/04/2020 | - | |
MAXCYTE, INC. | Directeur/Membre du Conseil | 15/06/2021 | - |
Independent Dir/Board Member | 15/06/2021 | - | |
Hemmo Pharma LLP | Directeur/Membre du Conseil | - | - |
Corporate Officer/Principal | - | - | |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Directeur/Membre du Conseil | 04/05/2020 | - |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | Directeur/Membre du Conseil | - | - |
Corporate Officer/Principal | - | - | |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | Directeur/Membre du Conseil | 19/08/2021 | - |
Independent Dir/Board Member | 19/08/2021 | - |
Historique de carrière de Rekha Hemrajani
Anciens postes connus de Rekha Hemrajani
Sociétés | Poste | Début | Fin |
---|---|---|---|
JIYA ACQUISITION CORP. | Directeur/Membre du Conseil | 01/08/2020 | 01/11/2022 |
Directeur Général | 01/08/2020 | 01/11/2022 | |
ADVERUM BIOTECHNOLOGIES, INC. | Directeur/Membre du Conseil | 01/05/2019 | 12/05/2021 |
Independent Dir/Board Member | 01/05/2019 | 12/05/2021 | |
ARAVIVE, INC. | Directeur/Membre du Conseil | 09/01/2020 | 08/04/2020 |
Directeur Général | 09/01/2020 | 08/04/2020 | |
President | 09/01/2020 | 08/04/2020 | |
░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Rekha Hemrajani
Kellogg School of Management | Masters Business Admin |
University of Michigan | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 16 |
Inde | 3 |
Opérationnelle
Director/Board Member | 9 |
Corporate Officer/Principal | 5 |
Independent Dir/Board Member | 4 |
Sectorielle
Health Technology | 13 |
Consumer Services | 3 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 8 |
---|---|
SAGIMET BIOSCIENCES INC. | Health Technology |
RAPT THERAPEUTICS, INC. | Health Technology |
ARCUS BIOSCIENCES, INC. | Health Technology |
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
EXELIXIS, INC. | Health Technology |
ARAVIVE, INC. | Health Technology |
ALX ONCOLOGY HOLDINGS INC. | Health Technology |
MAXCYTE, INC. | Health Technology |
Entreprise privées | 7 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Health Technology |
Jiya Acquisition Corp.
Jiya Acquisition Corp. Financial ConglomeratesFinance Jiya Acquisition Corp. is a blank check company. The firm was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying promising opportunities in the biopharmaceutical sector. The company was founded in August 2020 and is headquartered in Palo Alto, CA. | Finance |
Hemmo Pharma LLP | |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | Health Technology |
- Bourse
- Insiders
- Rekha Hemrajani
- Expérience